AU503877B2 - Composition for enhancing pulmonary function in mammal - Google Patents

Composition for enhancing pulmonary function in mammal

Info

Publication number
AU503877B2
AU503877B2 AU27412/77A AU2741277A AU503877B2 AU 503877 B2 AU503877 B2 AU 503877B2 AU 27412/77 A AU27412/77 A AU 27412/77A AU 2741277 A AU2741277 A AU 2741277A AU 503877 B2 AU503877 B2 AU 503877B2
Authority
AU
Australia
Prior art keywords
mammal
composition
pulmonary function
enhancing pulmonary
enhancing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU27412/77A
Other languages
English (en)
Other versions
AU2741277A (en
Inventor
Ne Pitts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of AU2741277A publication Critical patent/AU2741277A/en
Application granted granted Critical
Publication of AU503877B2 publication Critical patent/AU503877B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU27412/77A 1976-08-26 1977-07-28 Composition for enhancing pulmonary function in mammal Expired AU503877B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71790576A 1976-08-26 1976-08-26
USUS717,905 1976-08-26

Publications (2)

Publication Number Publication Date
AU2741277A AU2741277A (en) 1979-02-01
AU503877B2 true AU503877B2 (en) 1979-09-27

Family

ID=24883964

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27412/77A Expired AU503877B2 (en) 1976-08-26 1977-07-28 Composition for enhancing pulmonary function in mammal

Country Status (19)

Country Link
JP (1) JPS5329935A (cs)
AU (1) AU503877B2 (cs)
BE (1) BE858094A (cs)
CA (1) CA1092028A (cs)
DE (1) DE2737735C3 (cs)
DK (1) DK354377A (cs)
FR (1) FR2362629A1 (cs)
GB (1) GB1541991A (cs)
GR (1) GR68687B (cs)
HK (1) HK30981A (cs)
IE (1) IE45768B1 (cs)
IL (1) IL52588A (cs)
LU (1) LU78022A1 (cs)
MY (1) MY8100263A (cs)
NL (1) NL170367C (cs)
NZ (1) NZ184746A (cs)
PT (1) PT66866B (cs)
SE (1) SE7708307L (cs)
ZA (1) ZA774474B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63156327U (cs) * 1987-04-02 1988-10-13

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899436A (en) * 1959-08-11 chjch
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
US3786160A (en) * 1971-02-16 1974-01-15 Pfizer Use of 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)-pyridines as bronchodilators

Also Published As

Publication number Publication date
DE2737735B2 (de) 1979-03-08
PT66866B (en) 1978-12-29
FR2362629B1 (cs) 1980-07-11
NZ184746A (en) 1980-02-21
NL7708732A (nl) 1978-02-28
DK354377A (da) 1978-02-27
IL52588A (en) 1980-07-31
ZA774474B (en) 1978-06-28
DE2737735A1 (de) 1978-03-02
IE45768B1 (en) 1982-11-17
DE2737735C3 (de) 1979-10-25
AU2741277A (en) 1979-02-01
NL170367C (nl) 1982-11-01
LU78022A1 (fr) 1979-05-23
CA1092028A (en) 1980-12-23
MY8100263A (en) 1981-12-31
IE45768L (en) 1978-02-28
BE858094A (fr) 1978-02-27
JPS5329935A (en) 1978-03-20
GB1541991A (en) 1979-03-14
HK30981A (en) 1981-07-10
FR2362629A1 (fr) 1978-03-24
SE7708307L (sv) 1978-02-27
PT66866A (en) 1977-08-01
IL52588A0 (en) 1977-10-31
GR68687B (cs) 1982-02-01

Similar Documents

Publication Publication Date Title
AU509825B2 (en) Isocyanate-prepolymer composition
AU506640B2 (en) APH-indicator composition
JPS5359016A (en) Pharmatoceutical composition
MY8300030A (en) Anti biotic-containing composition
JPS5316787A (en) Specificcreactive composition
AU2732277A (en) Soil-hardening composition
JPS5355360A (en) Heattactivating composition
AU511759B2 (en) Detergent composition
AU496813B2 (en) Improvements in games
JPS52117437A (en) Antiicoccidium composition
AU2245577A (en) Sunscreen composition
JPS52142752A (en) Moistureeresistant composition
IL51365A0 (en) Coccidiocidal composition
IE44735L (en) Fibrinogenase composition
AU503877B2 (en) Composition for enhancing pulmonary function in mammal
JPS52103201A (en) Photoosensitive composition
AU512477B2 (en) Glass-size composition
AU524703B2 (en) Polymerizable composition
HK47880A (en) Antipeptic ulcer composition
JPS5296102A (en) Photoosensitive composition
JPS52142292A (en) Conductiveeresin composition
JPS5291022A (en) Shirasuuballoon composition
JPS5312923A (en) Solid composition
AU513646B2 (en) Improvements in vices
AU515572B2 (en) Foundry composition